Collins expects FDA to expand booster recommendation in "coming weeks"
Dr. Francis Collins, the director of the National Institutes of Health, says he expects an FDA panel to "extend boosters beyond the list that they approved on Friday."
Food and Drug Administration
FDA panel approves Pfizer boosters for some
President Biden’s plan to give booster shots to most Americans was rejected by an FDA advisory panel just days before its rollout. The panel did, however, endorse a Pfizer booster shot for older Americans or those at risk of serious disease. Jonathan Vigliotti has the latest.
Dr. Scott Gottlieb extended interview, part 1
In this extended version of an interview that aired on Sunday, September 19, 2021, Dr. Scott Gottlieb discusses the missteps of the U.S. response to the pandemic and his new book, "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic."
Dr. Scott Gottlieb extended interview, part 2
In this extended version of an interview that aired on Sunday, September 19, 2021, Dr. Scott Gottlieb discusses the missteps of the U.S. response to the pandemic and his new book, "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic."
Debate over COVID booster shots continue
The debate over the necessity of COVID-19 booster shots is becoming yet another point of contention in public health discourse. Meanwhile, there are signs of hope as the U.S. reported two straight weeks of decline in new infections. Anthony Pura reports.
FDA panel recommends COVID booster for some
An independent FDA panel recommended this week that some Americans, including those over the age of 65 and those who are at risk of serious disease, get the COVID-19 booster shot. But the panel stopped short of recommending it for the general public. Dr. Geeta Swamy, the associate vice president of research and a professor of obstetrics and gynecology at Duke University, explains to CBSN's Lana Zak if pregnant women should be part of the "at-risk" group.
FDA says most Americans don't need booster shot
The FDA is recommending coronavirus booster shots for people 65 and older or with compromised immune systems. It declined to recommend a third shot for the general public. Dr. William Schaffner, who is on the CDC's advisory committee on immunization, joined CBSN to discuss the FDA's decision.
FDA votes for booster shot for ages 65+
The FDA advisory panel voted to recommend Pfizer booster shots for people 65 and over and others at higher risk of serious illness. It was the first vaccine to be authorized for emergency use and was used in the earliest stages of America's vaccination program. But the FDA is saying the boosters are not for everybody. Michael George reports.
FDA panel: Most don't need Pfizer boosters
A Food and Drug Administration advisory committee voted to recommend only people over the age of 65 or who are immunocompromised need third doses of the Pfizer vaccine. CBS News correspondent Jonathan Vigliotti reports the decision upends the Biden administration's plans to roll out a mass booster program Monday. Then, Dr. Hilary Fairbrother, an emergency medicine physician, joins CBSN's Lana Zak to explain what this vote means for the future of COVID-19 vaccine boosters.
FDA to vote on Pfizer's COVID booster shot
A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News' Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, and CBS News researcher Max Bayer has more on the FDA hearing.
What the FDA's Pfizer booster decision means
Amid confusion about whether COVID-19 booster shots are necessary, Dr. Jon LaPook explains what the FDA’s decision on the Pfizer booster shot means and who should be getting them.
FDA hampers Biden’s COVID booster plan
Prior to the FDA's announcement Friday that a COVID-19 booster shot is only recommended for some Americans, President Biden planned to begin offering booster shots to the general public as soon as next week. Nancy Cordes has more on how Mr. Biden has softened his position.
"CBS This Morning" takes a look at some of the day's headlines from around the globe
"CBS This Morning" takes a look at some of the day's headlines from around the globe.
Doctors Jon Lapook and Holly Phillips discuss the major medical stories of the week including a possible ban on trans fats by the FDA
Doctors Jon Lapook and Holly Phillips discuss the major medical stories of the week including a possible ban on trans fats by the FDA on "CBS This Morning: Saturday."
FDA approves Pfizer's COVID-19 vaccine
The FDA has approved the nation's first COVID-19 vaccine. About 3 million doses of Pfizer's vaccine are expected to be shipped as early as the weekend. Tom Hanson reports on the beginning of what will be the largest vaccination effort in American history.
Panel backs Johnson & Johnson COVID vaccine
A panel of experts with the Food and Drug Administration recommended the COVID-19 vaccine from Johnson & Johnson for emergency use authorization. Nearly 4 million shots could be shipped out as soon as Sunday. The new shipment comes with fresh warnings from top health officials who say that states should not start relaxing restrictions. Michael George reports.
FDA issues emergency approval for remdesivir
President Trump left for Camp David this weekend, his first trip outside of the White House since late March. On Friday, he announced the FDA has approved an emergency order for remdesivir. The drug has been touted as a new potential treatment for severe cases of COVID-19. Nikole Killion reports on the Trump administration's efforts to find a vaccine -- dubbed "Operation Warp Speed."
FDA panel meets to discuss booster shots
The White House wants to begin offering COVID-19 booster shots to the general public as soon as next week. An FDA panel is meeting today to debate whether to OK that. CBS News senior White House and political correspondent Ed O'Keefe joined CBSN with more on that plus other issues on the president's agenda.
Biden goes after wealthy in speech on economy
In a speech promoting his economic agenda, President Biden on Thursday criticized the wealthy and corporations for not paying their fair share of taxes. CBS News chief White House correspondent Nancy Cordes, Axios' political reporter Sarah Mucha, and The Washington Post's Capitol Hill reporter Rhonda Colvin join CBSN's "Red & Blue" anchor Elaine Quijano with the details, and the latest on the White House's effort to address rapper Nicki Minaj's questions about vaccines.
Scientists split on COVID vaccine booster
Scientists are debating whether COVID-19 booster shots are necessary for those who are not immunocompromised, with some saying the vaccine is effective enough on its own. An FDA committee will vote Friday whether to approve Pfizer's booster shot. Jonathan Vigliotti reports.
Should the general population get booster shots
The FDA will decide on Friday whether some vaccinated people should get COVID-19 booster shots. Dr. Marcos Mestre, vice president and chief medical officer of Nicklaus Children's Hospital, joins CBSN with more.
FDA to meet over COVID booster shots
An FDA advisory committee will meet Friday to discuss and vote on COVID-19 vaccine booster shots. As Jonathan Vigliotti reports, there are conflicting studies on whether another shot is already needed. Then, Dr. Andre Campbell, a critical care physician and a professor at the University of California at San Francisco, joins CBSN's Lana Zak to explain what the science is telling us.
1 in 500 Americans have died from COVID-19
The pandemic continues to devastate the U.S., as 1 in 500 Americans have died from COVID-19, according to Centers for Disease Control and Prevention data. Meanwhile, the country is pushing its vaccination efforts amid talks of implementing possible booster shots. Urgent care nurse practitioner Justin Gill joined CBSN to talk about the latest coronavirus news.
The fight over COVID-19 booster shots heats up
In Tennessee, less than 45% of the population is fully vaccinated. The state leads the nation in the number of new COVID-19 cases per capita.
FDA neutral on COVID boosters
The FDA is not yet taking a definitive stance on whether or not booster shots are needed to help protect people from coronavirus infections. A key advisory committee is set to meet to discuss authorizing an extra dose of Pfizer's vaccine in the coming days. CBS News correspondent Omar Villafranca reports from Tennessee, where first vaccine doses remain low. Then, Dr. Adam Brown, an emergency physician and the COVID-19 national task force chair at Envision Healthcare, joins CBSN's Lana Zak to discuss the latest on the pandemic.
Interactive
These documents tell the story of the Cornell rape allegations
Hurricane Isaias now a Category 3 storm as it threatens northern Gulf Coast
Live
Iran's Houthi allies step up deadly attacks on Saudi Arabia
ICE agent shoots man in New York City's Marble Hill, authorities say
Fort Hood shooter's execution will be livestreamed, Pentagon says
Nobel Peace Prize awarded to former ICC judge Navanethem "Navi" Pillay
Exclusive
Obama raises more than $13 million for Democrats
8 hospitalized after turbulence forces flight to divert to MIA, officials say
